Zuffa Statement on Thiago Tavares

Zuffa, LLC, owner of the Ultimate Fighting Championship®, released the following statement today regarding drug test results from UFC on FX 7 that took place in Sao Paulo, Brazil, on January 19, 2013.

All 22 fighters on the UFC on FX 7 card were drug tested at the event and all fighters passed their drug tests with the exception of Thiago Tavares. The results for Tavares showed the presence of  Drostanolone, an anabolic steroid and banned substance. Tavares has been informed that he will receive a 9-month suspension retroactive to the date of the event and that he must pass a drug test upon completion of the suspension before receiving clearance to compete again.

To dispel rumors that have been circulated, Zuffa wishes to clarify that Vitor Belfort’s drug test results were negative and did not indicate the presence of any performance enhancing drugs.

Belfort has been on a medically approved testosterone replacement therapy (TRT) regimen under the supervision of a medical doctor from the State of Nevada, after being diagnosed with hypogonadism, or low testosterone. The purpose of a medically administered TRT regimen is to allow patients with hypogonadism to maintain testosterone levels within a range that is normal for an adult male.  

メディア

最新
UFC 211 event at the American Airlines Center on May 13, 2017 in Dallas, Texas. (Photos by Josh Hedges/Zuffa LLC/Zuffa LLC via Getty Images)
2017/05/13
UFC 211の全試合終了後に開かれる記者会見の模様
2017/05/13
During the UFC 211 weigh-in at the American Airlines Center on May 12, 2017 in Dallas, Texas. (Photo by Josh Hedges/Zuffa LLC/Zuffa LLC via Getty Images)
2017/05/12
The UFC Summer Kickoff Press Conference at the American Airlines Center on May 12, 2017 in Dallas, Texas. (Photos by Zuffa LLC/Zuffa LLC via Getty Images)
2017/05/12